Abstract:The mechanism of action of retinoic acid (RA) is of broad relevance to cell and developmental biology, nutrition, and cancer chemotherapy. RA is known to induce expression of the Burkitt's lymphoma receptor 1 (BLR1) gene which propels RA-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells, motivating the present analysis of transcriptional regulation of blr1 expression by RA. The RA-treated HL-60 cells used here expressed all RA receptor (RAR) and retinoid X receptor (RXR) subtypes (as detected by Northern analysis) except RXRgamma. Treatment with RAR- and RXR-selective ligands showed that RARalpha synergized with RXRalpha to transcriptionally activate blr1 expression. A 5'-flanking region capable of supporting RA-induced Nil activation in HL-60 cells was found to contain a 205-bp sequence in the distal portion that was necessary for transcriptional activation by RA. Within this sequence DNase I footprinting revealed that RA induced binding of a nuclear protein complex to an element containing two GT boxes. Electromobility shift assays (EMSAs) and supershift assays showed that this element bound recombinant RARalpha and RXRalpha. Without RA there was neither complex binding nor transcriptional activation. Both GT boxes were needed for binding the complex, and mutation of either GT box caused the loss of transcriptional activation by RA. The ability of this cis-acting RAR-RXR binding element to activate transcription in response to RA also depended on downstream sequences where an octamer transcription factor 1 (Oct1) site and a nuclear factor of activated T cells (NFATc) site between this element and the transcriptional start, as well as a cyclic AMP response element binding factor (CREB) site between the transcriptional start and first exon of the blr1 gene, were necessary. Each of these sites bound its corresponding transcription factor. A transcription factor-transcription factor binding array analysis of nuclear lysate from RA-treated cells indicated several prominent RARalpha binding partners; among these, Oct1, NFATc3, and CREB2 were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex. RA upregulated expression of these three factors. In sum the results of the present study indicate that RA-induced expression of Nil expression depends on a novel RA response element. This cis-acting element approximately 1 kb upstream of the transcriptional start consists of two GT boxes that bind RAR and RXR in a nuclear protein complex that also contains Oct1, NFATc3, and CREB2 bound to their cognate downstream consensus binding sites.

A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression.

A Retinoic Acid Receptor-Specific Element Controls the Retinoic Acid Receptor-Beta Promoter

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter.

Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells.

RAR72 Expression is Regulated Through a Retinoic Acid Response Element Embedded in Sp1 Sites

A Mapk-Positive Feedback Mechanism for Blr1 Signaling Propels Retinoic Acid-Triggered Differentiation and Cell Cycle Arrest

Retinoic Acid Activates Human Inducible Nitric Oxide Synthase Gene Through Binding of Rar Alpha/Rxr Alpha Heterodimer to A Novel Retinoic Acid Response Element in the Promoter

Regulation Of Rar Beta Expression By Rar- And Rxr-Selective Retinoids In Human Lung Cancer Cell Lines: Effect On Growth Inhibition And Apoptosis Induction

Lineage Restriction of the RARalpha Gene Expression in Myeloid Differentiation.

All-trans-retinoic Acid and Erk1/2 Signaling Synergistically Regulate the Expression of CD300B in Human Monocytic Cells

Transcription Factor MafB is a Mediator of Retinoic Acid‐induced Monocytic Cell Differentiation

Retinoic Acid Nuclear Receptor Α (rarα), a Major Role in Mediating Retinoids Inhibition of Growth in Human Breast Carcinoma Cells

A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene.

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Constitutive Activation of Retinoic Acid Receptor Β2 Promoter by Orphan Nuclear Receptor TR2

Retinoic Acid (RA) Receptor Transcriptional Activation Correlates with Inhibition of 12-O-tetradecanoylphorbol- 13-Acetate-induced Ornithine Decarboxylase (ODC) Activity by Retinoids: A Potential Role Fortrans-Ra-induced ZBP-89 in ODC Inhibition

Retinoic Acid Regulates Mouse B‐cell Activation and Differentiation Induced by Engagement of CD40, B‐cell Antigen Receptor and Cytokine IL‐4

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells

Receptor Unique Anti-Activator Protein-1 Activity of Retinoic Acid Updated Version